Fulphila® (pegfilgrastim-jmdb)
for Neutropenia

Fulphila (pegfilgrastim-jmdb) is used to prevent neutropenia, a condition caused by chemotherapy that results in a low white blood cell count. It is a man-made version of a protein that stimulates the production of white blood cells, which are essential for fighting infections. Fulphila helps increase white blood cell production in patients whose ability to make these cells is reduced by chemotherapy, aiding in infection prevention.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Neutropenia